Cannabidiol prescribing in the United States: An analysis of real-world data
Abstract Background: Off-label prescribing of Epidiolex® (pharmaceutical cannabidiol) comes with both potential benefits and risks for patients. The aims of…
Abstract Background: Off-label prescribing of Epidiolex® (pharmaceutical cannabidiol) comes with both potential benefits and risks for patients. The aims of…
Keywords: Cannabis Clinical Outcomes Research Conference, Conference proceedings, Medical marijuana, Cannabis, Marijuana safety, Marijuana clinical outcomes, Public health Authors: Amie…
Abstract Aim: Our objective was to systematically assess the prevalence and clinical features of adverse events related to interactions between…
Abstract Purpose: Over 75% of Americans have legal access to medical cannabis, though physical access is not uniform and can…
Abstract Dysfunction or damage to the nervous system may develop into and result in a chronic pain condition known as…
Abstract Beneficial cannabis use has sparked growing interest among researchers, leading to an increase in empirical studies exploring its phytochemistry…
Abstract Objectives: Medical cannabis (MC) has been found effective in treating multiple symptoms commonly experienced by older adults; however, residents…
Abstract Changes in chronic noncancer pain treatment have led to decreases in prescribing of opioids and increases in the availability…
Abstract Background: Approximately 5% of breastfeeding women report using cannabis. Little is understood about perceived benefits and risks of cannabis…
Abstract Preclinical evidence indicates the potential anti-tumor capabilities of cannabinoids in prostate cancer (PC). We undertook a cross-sectional study using…